Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 10 Sponsors

Feb 2, 2026 · House

On 1st reading, House Calendar

Jan 30, 2026 · House

Placed on House Calendar

Jan 29, 2026 · House

On 1st reading, Special Calendar

Jan 29, 2026 · House

Postponed on 1st reading, Special Calendar, until January 30, 2026

Jan 28, 2026 · House

By substitute, do pass

Jan 22, 2026 · House

Markup Discussion

Jan 21, 2026 · House

Filed for introduction

Jan 21, 2026 · House

To Health and Human Resources

Jan 21, 2026 · House

Introduced in House

Jan 21, 2026 · House

To House Health and Human Resources

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 12%, measured from WV's completed sessions
Momentum -4 33/100 from the pace of recorded action
Time since last action -22 252 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.